1Analysis of the meanings of equivalence and the required statistical evaluation methodsTAN De-jiang, FENG Guo-shuang, ZHU Rong-die, YANG Hua-xin2881-28862Policies to promote use of generic drugs in developed countriesCHEN Jing, SANG Xiao-dong, REN Qiao-yu, SHI Lu-wen2887-28913Sample size determination and post hoc statistical power in bioequivalence studiesDAI Jun-hao, ZHENG Qiang2892-28974Sample size calculation for average bioequivalence studies of generic drugsMEI He-kun, WANG Jin, CHAI Dong, CAI Yun, WANG Rui2898-29025Generic drug labeling management of FDA and EMAGAO Li-li, LI Min, WANG Yu-zhu, LI Rui-feng, YANG Jin-bo2903-29076Lessons learned from filing inspection of FDA to assist quality consistency evaluation of generic drugsWANG Yang, LI Mei2908-29127The requirements for in vivo bioequivalence studies for solid products of oral drugs with narrow therapeutic indexes by FDA, HC, EMA, PMDA and CFDAXU Wen-pin, LI Li, CHEN Li-xun, HE Rui-rui, HAN Hong-can, YANG Jin-bo2913-29178Evaluation methods of in vitro release rate of peptide microsphere injections: a reviewLIANG Yuan-ying-zhu, LIN Xiao-ming, LIU Wan-hui, YU Li-ju, YANG Hua-xin2918-29239The application of European Public Assessment Reports in the identification of reference medicinal products for generic medicinal productsXU Ming-di, NIU Jian-zhao, YANG Dong-sheng, LI Tao, QIAO Li-tao, GAO Tian-tian2924-292710Introduction of the WHO prequalification of medicines programme and comparator productCHEN Jie, YANG Dong-sheng, NIU Jian-zhao2928-293211The introduction of the reference medicinal products for marketing authorisation application of generic medicinal products in the EUXU Ming-di, NIU Jian-zhao, YANG Dong-sheng, LI Tao, QIAO Li-tao, GAO Tian-tian2933-293612Development of a determination method for free polysaccharide content in serotype 6B pneumococcal polysaccharide conjugateLIU Ai-ping, REN Zhen-yun, LIU Qian, LUO Shu-quan, CHEN Xiao-hang, LI Xian-lin, DU Jiao, XIE Gui-lin2937-294213Research progress in long-acting human factor ⅦaLIANG Ming-zheng, MA Shan-shan, MA Su-yong2943-294614Research progress of mitosis catastrophe targeted medicines on tumor cellsZOU Xiang, CHEN Min, QU Zhong-yuan, JI Yu-bin2947-295115The values and applications of minipig in nonclinical drug safety evaluationZHAO Shi-bo, LI Cai-xia, YIN Ji-ye2952-295916Efficacy of cyclosporine A eye drops combined with loteprednol eye drops in treatment of vernal keratoconjunctivitisSHANG Qing-li, WANG Xin, MA Hong-lei, XU Man2960-296317Impact of Yangyinqingfeihuoxue prescription on Th17/Treg balance in peripheral blood of rats with radioactive pulmonary fibrosisDONG Guang-tong, LI Zheng, QI Xin, ZHOU Zhou, WU Xiao-hui, HOU Wei2964-296918Resveratrol attenuates type 2 diabetes-induced cardiomyopathy through promoting autophagy by up-regulating SIRT1DU Hui-xue, JIANG Hai-yu, HU Ying-ying, JIA Dan, HAI Xin2970-297719Prediction and selection of raw materials for reference standards of cefoxitin sodiumLI Yue-yue, YAO Shang-chen, ZHANG Xia, LIU Wan-hui, HU Chang-qin2978-298320Effect of substitution degree of hydroxypropyl starch on properties of vacant capsulesWANG Xiang-feng, ZHANG Jia-wei, SHUAI Fang-wen, LI Hui-yu2984-2988 